CLEC4D

CLEC4D (CLECSF8/Dectin-3/MCL) is a myeloid-expressed type II transmembrane C-type lectin receptor that functions as a pattern-recognition and phagocytic receptor in antimicrobial innate immunity (PMID:14971047, PMID:25674984). It is displayed on neutrophils and monocytes and lost upon their differentiation into dendritic cells or macrophages, and its C-type lectin domain mediates ligand recognition and, in non-myeloid contexts, intracellular retention (PMID:22689578). CLEC4D recognizes α-mannans on Candida albicans hyphae and drives NF-κB activation, and despite lacking a cytoplasmic signaling motif it triggers Syk-dependent phagocytosis, proinflammatory cytokine production, and the respiratory burst (PMID:22689578, PMID:23911656). Its activity is organized through obligate partnership with Mincle: CLEC4D binds Mincle via its stalk region—four hydrophobic residues are required—to post-translationally stabilize and promote Mincle surface expression, and CLEC4D itself depends on FcRγ and Mincle for surface translocation through a two-step mechanism in which MyD88-driven microbial induction of Mincle licenses the CLEC4D/Mincle heterodimer to exit intracellular stores to the cell surface (PMID:25888641, PMID:26558717, PMID:27005451). In vivo, CLEC4D is non-redundant for control of C. albicans and Mycobacterium tuberculosis infection and for resolution of Klebsiella pneumoniae pneumonia, where it governs neutrophil turnover rather than direct bacterial killing, but it is dispensable against Cryptococcus neoformans, defining pathogen-specific functional boundaries (PMID:23911656, PMID:25674984, PMID:28107361, PMID:23709686).

1. 2004 Medium

   Established CLEC4D as a monocyte/macrophage-restricted cell-surface glycoprotein capable of internalization, framing it as a candidate endocytic immune receptor before any ligand was known.

   Evidence Molecular cloning, Western blot, and cross-linking/internalization assay in transfected cells

   PMID:14971047

   Open questions at the time

   • No ligand identified
   • No signaling pathway or adaptor defined
   • Endocytic function inferred from cross-linking, not physiological ligand
2. 2012 Medium

   Resolved how a receptor lacking a cytoplasmic signaling motif transmits signals, showing CLEC4D activates Syk to drive phagocytosis, cytokine production, and respiratory burst while not using known adaptors, implying a novel adaptor partner.

   Evidence Flow cytometry, reciprocal Co-IP excluding DAP10/DAP12/FcRγ, reporter and functional assays, oligosaccharide microarrays in myeloid cells

   PMID:22689578

   Open questions at the time

   • The adaptor coupling CLEC4D to Syk was not identified
   • Physiological ligand not defined here
   • Mechanism of Syk recruitment unresolved
3. 2013 High

   Identified CLEC4D as an α-mannan receptor that heterodimerizes with Dectin-2 for enhanced ligand binding and NF-κB-driven inflammation, and demonstrated non-redundant in vivo roles spanning antifungal, antimycobacterial, and Gram-negative pneumonia resolution.

   Evidence Reciprocal Co-IP, NF-κB reporter and ligand-binding assays, Clec4d knockout mouse infection models (C. albicans, M. tuberculosis, K. pneumoniae)

   PMID:23709686 PMID:23911656 PMID:25674984

   Open questions at the time

   • Whether Dectin-2 and Mincle partnerships are distinct or overlapping was not reconciled
   • Mechanism of neutrophil resolution in pneumonia not molecularly defined
   • Phagocytosis vs signaling contributions not separated in vivo
4. 2016 High

   Extended the protective antifungal role to mucosal immunity, showing CLEC4D supports macrophage phagocytosis, killing, NF-κB activation, and tissue-repair signaling that constrains commensal fungal overgrowth in colitis.

   Evidence Clec4d knockout DSS-colitis model, fungal burden, macrophage phagocytosis/killing assays, NF-κB reporter, conditioned-media tissue repair assay

   PMID:27280399

   Open questions at the time

   • Tissue-repair effector(s) in conditioned media not identified
   • Direct receptor-ligand engagement with C. tropicalis not structurally defined
5. 2015 High

   Defined the molecular basis of the CLEC4D–Mincle partnership, mapping a stalk-region interaction (four hydrophobic residues) that post-translationally promotes Mincle surface expression and is required for TDM responses.

   Evidence Co-IP, surface flow cytometry, Western blot, MCL transgenic/knockout BMDCs, MCL-4S domain mutagenesis with functional rescue

   PMID:25888641

   Open questions at the time

   • Structural detail of the stalk interface not resolved
   • How heterodimer stabilization translates to enhanced signaling not fully defined
6. 2015 High

   Established that CLEC4D surface expression itself depends on FcRγ and Mincle and that CLEC4D and Mincle are interdependently co-regulated and microbially induced during infection.

   Evidence Monoclonal antibody flow cytometry, Co-IP for FcRγ/Mincle, in vivo BCG infection, TLR-agonist stimulation assays

   PMID:26558717

   Open questions at the time

   • Mechanism of FcRγ requirement for surface delivery not detailed
   • Distinction between Mincle and Dectin-2 partnerships not reconciled
7. 2016 Medium

   Integrated the regulatory logic into a two-step model in which MyD88-driven Mincle induction licenses constitutively expressed CLEC4D to exit intracellular stores as a CLEC4D/Mincle heterodimer to the surface.

   Evidence Western blot, flow cytometry, Co-IP, MyD88-deficient cells, gene expression epistasis

   PMID:27005451

   Open questions at the time

   • Trafficking machinery mediating co-translocation not identified
   • Single-lab epistasis without orthogonal confirmation
8. 2017 Medium

   Delimited the receptor's protective scope by showing CLEC4D is dispensable for control of Cryptococcus neoformans, indicating pathogen-specific rather than universal antimicrobial function.

   Evidence Clec4d knockout C. neoformans pulmonary infection, CFU, flow cytometry, phagocytosis and cytokine assays

   PMID:28107361

   Open questions at the time

   • Does not exclude redundancy with other receptors for this pathogen
   • Negative result limited to the murine pulmonary context tested

• The structural basis of CLEC4D heterodimerization and its quantitative contribution to signaling versus phagocytosis in vivo remain unresolved.
• No structure of CLEC4D alone or in heterodimer
• Trafficking machinery for surface delivery unknown
• Effectors mediating tissue repair and neutrophil resolution unidentified